Force of Impact in a Tackle
From the G-Max ratings of different playing surfaces to the calculation of force, it is evident that the toll on ...
For Athletes, Sleep Performance is Key
A healthy sleep pattern can be a stealthy game plan for athletes to gain an edge over their opponents, something ...
Police Shouldn’t Respond to Mental Health Crises
Cities are experimenting with new ways to meet the rapidly increasing demand for behavioral health crisis intervention.
Disabled Voters Continue Facing Barriers
Voters with disabilities face a range of barriers, while compliance with disability access laws at polling sites is under-enforced.
How Do I Start Longevity Medication?
Longevity medicine, also known as regenerative medicine, is a revolutionary field that aims to enhance our health and increase our ...
CSI: OPIOIDs: A Call for Participants
The CSI:OPIOIDs research study team carries out interviews with anyone who lost a loved one to suicide following an opioid ...
Imprisoned Physician Targeted for Treating Opioids Gets New Trial
The Supreme Court ruling has begun to protect physicians, though the media narrative might not want to believe it.
Patients: Start ‘Loud Budgeting’
In today's complex healthcare landscape, patients often find themselves burdened with unexpected medical expenses.
Post-op Pain Relief for Mr. Merrick Garland?
Attorney General Merrick Garland is undergoing back surgery. We ponder what type of pain relief he will receive.
Syphilis: Back With a Vengeance
Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease.
Suicide is an Epidemic Most Physicians Cannot Treat
Suicide has reached epidemic proportions in the US − yet medical students still don’t receive adequate training to treat suicidal ...
SAMHSA Makes Permanent Increased Access to OUD Medications
The Biden administration announced that policies put in place during the pandemic will continue permanently.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
Growth Hormone Secretagogues and the Longevity Trade-Off
-
GLP-1 Agonists Beyond Obesity: The Expanding Therapeutic and Optimization Frontier
-
The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex
-
The Second Reader That Never Sleeps: Large Language Models and Clinical Decision-Making
-
The Peptide Underground: Clinical Evidence, Compounding Markets, and the Optimization Economy
